JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB99761

Mouse monoclonal [JDC-10] Anti-Human IgG Fc (PE)

Be the first to review this product! Submit a review

|

(3 Publications)

Suitable for Dot, ELISA, WB, IHC-Fr, ICC/IF. Cited in 3 publications.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

  • Unconjugated

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc

  • Alkaline Phosphatase

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc (Alkaline Phosphatase)

  • HRP

    Mouse monoclonal [JDC-10] Anti-Human IgG Fc (HRP)

Key facts

Host species

Mouse

Target species

Human

Target isotype

IgG

Target specificity

Fc region

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

PE

Excitation/Emission

Ex: 480;565nm, Em: 578nm

Applications

Dot, IHC-Fr, ELISA, ICC/IF, WB

applications

Clonality

Monoclonal

Clone number

JDC-10

Isotype

IgG1

Light chain type

kappa

Specificity

Reacts with the Fc portion of the heavy chain of all subclasses of human IgG.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Dot": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>+ slot-immunoblotting: Use at an assay dependent dilution.</p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"0.2 µg for 10^6 Cells", "notes":"<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.3 Preservative: 0.1% Sodium azide Constituents: Sucrose, PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store in the dark

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Mediates IgG effector functions on monocytes triggering ADCC of virus-infected cells.
See full target information IGHG1

Additional targets

IGHG4,IGHG2,IGHG3

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

The Lancet. Microbe 6:100987 PubMed39832516

2025

Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study.

Applications

Unspecified application

Species

Unspecified reactive species

Scott Jones,Bethany Hicks,Helen Callaby,Daniel Bailey,N Claire Gordon,Tommy Rampling,Catherine Houlihan,Rachael Jones,Marcus Pond,Ravi Mehta,Deborah Wright,Clarissa Oeser,Simon Tonge,Ezra Linley,Cathy Rowe,Bassam Hallis,Ashley Otter

Cancer biology & medicine : PubMed34623791

2021

Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion integrin/BRAF/TAK1/ERK/ETV4 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Panpan Ma,Xinxin Jin,Zhiwei Fan,Zhou Wang,Suhui Yue,Changyue Wu,Shiyin Chen,Yuanyuan Wu,Miaomiao Chen,Donghua Gu,Siliang Zhang,Renfang Mao,Yihui Fan

Frontiers in immunology 9:909 PubMed29755476

2018

Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency.

Applications

Unspecified application

Species

Unspecified reactive species

Andri L Lemarquis,Helga K Einarsdottir,Rakel N Kristjansdottir,Ingileif Jonsdottir,Bjorn R Ludviksson
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com